European Journal of Clinical Pharmacology

, Volume 63, Issue 5, pp 471–478

Does coronary artery bypass surgery affect metoprolol bioavailability


  • Antti Valtola
    • Department of Cardiothoracic SurgeryKuopio University Hospital
    • Department of Anesthesiology and Intensive CareKuopio University Hospital
    • Department of Pharmacology and ToxicologyUniversity of Kuopio
  • Merja Gergov
    • Department of Forensic MedicineUniversity of Helsinki
  • Ilkka Ojanperä
    • Department of Forensic MedicineUniversity of Helsinki
  • Veli-Pekka Ranta
    • Department of PharmaceuticsUniversity of Kuopio
  • Tapio Hakala
    • Department of SurgeryNorth Karelia Central Hospital
Pharmacokinetics and Disposition

DOI: 10.1007/s00228-007-0276-6

Cite this article as:
Valtola, A., Kokki, H., Gergov, M. et al. Eur J Clin Pharmacol (2007) 63: 471. doi:10.1007/s00228-007-0276-6



β-blockers are commonly administered in patients with coronary artery bypass surgery (CABG). Despite this therapy, however, the incidence of postoperative atrial fibrillation (AF) is high (9–19%), and it is unknown why the β-blockers do not reduce the incidence of AF more efficiently. In this pharmacokinetics study, in which the patients acted as their own controls, we have evaluated the bioavailability of perioperative metoprolol tablets in CABG surgery patients.


Twelve male patients, aged 45–64 years, scheduled for CABG surgery were administered an initial 50 mg metoprolol tartrate tablet orally on the morning of the preoperative day and thereafter at 12-h intervals. Regular blood samples were collected up to 12 h after the first administration of the drug on the preoperative day as well on the first and third postoperative days. The plasma concentration for metoprolol was analyzed (limit of quantification = 0.001 mg/L) using liquid chromatography-tandem mass spectrometry.


The bioavailability of the metoprolol was significantly less on the first postoperative day, with AUC0–12 values ranging from 0.7 to 17.1 (median: 7.2) mg min/L, than on the preoperative day, with AUC0–12 values of 5.1–26.7 (12.6) mg min/L; however, it returned to the preoperative values on the third postoperative day, with AUC0–12 values of 3.5–25.2 (15.2) mg min/L. Similar changes were observed in Cmax values: preoperative Cmax ranged between 0.026 and 0.123 (0.060) mg/L, on the first postoperative day, the Cmax ranged between 0.003 and 0.093 (0.025) mg/L, and on the third postoperative day, the Cmax ranged between 0.009 and 0.136 (0.061) mg/L. There was no correlation between the pharmacokinetic parameters and patient characteristics, but both the preoperative Cmax and C60 correlated significantly with the postoperative Cmax (Pearson correlation coefficient: 0.61–0.72). One patient with one of the lowest rates and extent of metoprolol absorption developed AF.


This study indicates that the bioavailability of metoprolol is markedly reduced when administered in tablet form during the early phase after CABG.


AdministrationArea Under CurveAtrial fibrillationCoronary artery bypass grafting surgeryDrug administration routesMetoprololOralPharmacokinetics

Copyright information

© Springer-Verlag 2007